StockData
BeOne Medicines Ltd. logo

BeOne Medicines Ltd. (ONC) operating KPIs

ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)

Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –

BeOne Medicines external R&D — Other Internal Clinical & Preclinical Projects ($M) ($M)

Form 8-K EX-99.1 SSE STAR Market Annual Reports (688235.SS)

Latest, FY2025
312
Period ended Dec 31, 2025
Change on a year earlier
+44.8%
215 in FY2024
History
9 years
Since FY2017
Sources
7
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedExternal R&D — Other Internal Clinical & Preclinical Projects ($M) ($M)Year on yearSource
FY2025Dec 31, 2025312+44.8%8-K STAR Report (2026-04-14, 0001651308-26-000008) ↗
FY2024Dec 31, 2024215-14.5%8-K STAR Report (2026-04-14, 0001651308-26-000008) ↗
FY2023Dec 31, 2023252+149.9%8-K STAR Report (2025-04-28, 0001651308-25-000057) ↗
FY2022Dec 31, 2022101+26.6%8-K STAR Report (2024-04-26, 0001651308-24-000043) ↗
FY2021Dec 31, 202179.6+8.2%8-K STAR Report (2023-04-25, 0001651308-23-000061) ↗
FY2020Dec 31, 202073.5-13.3%8-K STAR Report (2022-04-28, 0001651308-22-000058) ↗
FY2019Dec 31, 201984.8+36.8%8-K STAR Report (2021-11-16, 0001651308-21-000229) ↗
FY2018Dec 31, 201862.0+454.1%8-K STAR Report (2021-11-16, 0001651308-21-000229) ↗
FY2017Dec 31, 201711.2–8-K STAR Report (2021-01-29, 0001104659-21-009496) ↗

Cite this data

StockData. (2026). BeOne Medicines External R&D — Other Internal Clinical & Preclinical Projects ($M) ($M), annual FY2017–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/rd_mol_other

See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.